From Aspara Biotech Research (the author's) website...An excerpt from their "legal" disclaimer...

If the report discusses a given stock as being overvalued and has a negative sentiment towards the stock, you should assume that Apsara has a short position in the stock covered, or otherwise benefits in the event of a price decline. If the report discusses a given stock as being undervalued and has a positive sentiment towards the stock, you should assume that Apsara has a long position in the stock covered, or otherwise benefits in the event of a price increase

I wouldn't take anything this company writes as anything more than them pushing their own agenda and hoping to make a quick buck pushing a few stocks one way or the other (whichever way they happen to be holding)...